Which neurons are involved in parkinsonism?

Questions 263

ATI RN

ATI RN Test Bank

Pharmacological Lifespan Treatment Questions

Question 1 of 5

Which neurons are involved in parkinsonism?

Correct Answer: C

Rationale: Parkinsonism is primarily characterized by the degeneration of dopaminergic neurons in the substantia nigra, leading to reduced dopamine levels in the basal ganglia. While cholinergic and GABAergic neurons play roles in basal ganglia circuitry, the core pathology of Parkinsonism centers on dopaminergic neuron loss, making 'Dopaminergic neurons' the correct choice.

Question 2 of 5

The main reason for avoiding the combined administration of levodopa and an inhibitor of both forms of monoamine oxidase is:

Correct Answer: B

Rationale: The correct answer is B) Hypertensive emergency. When levodopa, a medication used in the treatment of Parkinson's disease, is combined with a monoamine oxidase inhibitor (MAOI), it can lead to a potentially life-threatening hypertensive crisis. This is due to the inhibition of MAO enzymes, which normally break down tyramine found in certain foods. When MAO is inhibited, tyramine can accumulate and cause a sudden release of norepinephrine, leading to severe hypertension. Option A) Respiratory depression is not a common side effect of combining levodopa and MAO inhibitors. Levodopa itself may cause some respiratory issues, but not in combination with MAOIs. Option C) Acute psychotic reactions are also not directly associated with the combination of levodopa and MAO inhibitors. Psychiatric side effects are more commonly seen with other medications used in Parkinson's disease treatment. Option D) Cardiovascular collapse and CNS depression are not the primary concerns when combining levodopa and MAO inhibitors. While cardiovascular and CNS side effects can occur with these medications individually, the main risk with their combination is hypertensive crisis due to tyramine interaction. In an educational context, understanding drug interactions is crucial for healthcare professionals to ensure patient safety. Teaching the potential risks and consequences of combining specific medications can help prevent harmful outcomes and promote effective pharmacological management. This case highlights the importance of considering interactions between drugs and how they can impact physiological processes in the body.

Question 3 of 5

When carbidopa and levodopa are given concomitantly:

Correct Answer: D

Rationale: In pharmacological lifespan treatment, the concomitant administration of carbidopa and levodopa is a common practice in managing Parkinson's disease. The correct answer, D) All of the above, is the most appropriate choice because it encompasses the comprehensive effects of combining these two medications. A) Levodopa blood levels are increased, and drug half-life is lengthened: Carbidopa works by inhibiting the peripheral breakdown of levodopa, leading to higher levodopa levels in the bloodstream. This results in improved delivery of levodopa to the brain, enhancing its therapeutic effects. Additionally, carbidopa helps to extend the half-life of levodopa, allowing for more sustained symptom control. B) The dose of levodopa can be significantly reduced (by 75%), also reducing toxic side effects: By co-administering carbidopa with levodopa, the dose of levodopa required for optimal therapeutic effect can be substantially reduced. This reduction not only minimizes the risk of toxic side effects associated with high levodopa doses but also helps in managing long-term complications such as dyskinesias. C) A shorter latency period precedes the occurrence of beneficial effects: Carbidopa enhances the rapid and efficient absorption of levodopa in the intestine, leading to a shorter onset of action and quicker relief of symptoms. This reduction in latency period is crucial in improving patient outcomes and quality of life. Educational Context: Understanding the synergistic effects of carbidopa and levodopa is essential for healthcare professionals, especially those managing patients with Parkinson's disease. This knowledge helps in optimizing treatment strategies, minimizing side effects, and improving patient adherence to therapy. By grasping the mechanisms of action and benefits of combination therapy, practitioners can provide more effective care and enhance patient outcomes.

Question 4 of 5

Narcotics analgesics should:

Correct Answer: A

Rationale: In the context of pharmacological lifespan treatment, the correct answer is A) Relieve severe pain. Narcotic analgesics, such as opioids, are potent pain relievers commonly used to manage moderate to severe pain. These medications work by binding to opioid receptors in the brain, spinal cord, and other areas of the body to reduce the perception of pain. Option B) Inducing loss of sensation is typically associated with general anesthetics, not narcotic analgesics. Anesthetics are used to induce a reversible loss of sensation, consciousness, or both for medical procedures. Option C) Reducing anxiety and exerting a calming effect are effects more commonly associated with anxiolytics and sedatives, such as benzodiazepines, rather than narcotics. These medications are used to reduce anxiety and promote relaxation. Option D) Inducing a stupor or somnolent state is not a primary effect of narcotic analgesics. While these medications can cause drowsiness and sedation as side effects, the primary purpose of using narcotics is to relieve pain rather than inducing a state of stupor. Educationally, it is crucial for healthcare professionals to understand the specific actions and effects of different classes of medications to ensure safe and effective treatment for patients across the lifespan. Understanding the appropriate use of narcotic analgesics can help healthcare providers make informed decisions regarding pain management and minimize the risks of misuse or adverse effects associated with these medications.

Question 5 of 5

Tick narcotic analgesic, which is a phenylpiperidine derivative:

Correct Answer: C

Rationale: In this question, the correct answer is C) Fentanyl. Fentanyl is a phenylpiperidine derivative, making it the correct choice. Codeine (A) is an opioid analgesic but not a phenylpiperidine derivative. Dezocine (B) is also an opioid analgesic, but it belongs to the benzomorphan class, not phenylpiperidine. Buprenorphine (D) is a partial opioid agonist, but it is not a phenylpiperidine derivative. Educationally, understanding the chemical structure and classification of drugs is crucial in pharmacology. Knowing the specific characteristics of different drug classes helps healthcare professionals make informed decisions in prescribing medications and understanding their mechanisms of action. In this case, recognizing Fentanyl as a phenylpiperidine derivative can guide appropriate clinical use and management of pain in patients across the lifespan.

Access More Questions!

ATI RN Basic


$89/ 30 days

ATI RN Premium


$150/ 90 days

Similar Questions